Total testosterone falls about 0.4% a year with age. Free testosterone falls about 1.3% — more than three times faster. Both figures come from the European Male Ageing Study, which followed more than 3,000 men aged 40 to 79.[1]
That gap is the most useful thing on this page, because the number most men are shown is the one that moves slowest.
The commonly quoted figure is too high
"Testosterone drops 1–2% per year after 30" appears constantly, including in a lot of clinic marketing. The large longitudinal data does not support it for total testosterone — EMAS measured 0.4% per year.[1]
The decline is real, but it is gradual. A man does not fall off a cliff at 40. What he experiences over a decade is a slow drift, which is precisely why it gets attributed to work, stress or simply getting older.
Why free testosterone falls faster
Two things happen at once with age, and they compound.
Production declines gradually. The testes produce somewhat less, and the signalling from the pituitary that drives production becomes less efficient.
SHBG rises. Sex hormone-binding globulin increases with age, and it binds testosterone tightly enough to make it unavailable to tissue. So a larger share of whatever is produced is taken out of play.
The result: total testosterone declines slowly, while the usable fraction declines faster. EMAS put that at 1.3% a year for free testosterone against 0.4% for total.[1]
This is why a total testosterone reading can look reassuring in a man who has genuinely lost a meaningful amount of usable hormone. The mechanics are covered in free vs total testosterone.
Decline is not the same as deficiency
An important distinction, and the one most often blurred.
Age-related decline is a normal physiological process happening to every man. Hypogonadism is a clinical diagnosis — low morning testosterone confirmed on two separate occasions, together with symptoms.[2] Most men experiencing the ordinary decline never cross that threshold and do not need treatment.
Age alone is not a reason to treat. Symptoms plus confirmed low levels are.
What accelerates it
The rate is not fixed, and several contributors are modifiable:
Body fat. Adipose tissue converts testosterone to estradiol, and higher fat mass is associated with lower testosterone — a loop that reinforces itself.
Sleep. Most testosterone is produced during sleep. Chronic short or fragmented sleep measurably lowers it.
Chronic illness. Type 2 diabetes, metabolic syndrome and chronic inflammatory conditions are all associated with lower levels.
Medications. Opioids and glucocorticoids among others suppress production directly.
That list matters because it means the trajectory is partly within your control, in a way "it's just age" implies it isn't.
Frequently asked questions
Is 1–2% per year wrong? For total testosterone, the large longitudinal evidence points lower — around 0.4% a year.[1] The higher figures often circulating either refer to free testosterone, which does fall faster, or are simply repeated without a source.
What should my level be at my age? There is no age-adjusted target. Diagnosis rests on symptoms plus confirmed low morning testosterone, not on comparison to an age-matched average.[2]
My total is normal but I feel worse than I did at 35. Is that possible? Yes, and it is the common version of this. If SHBG has risen, free testosterone can be meaningfully lower while total still reads normal — which is why free testosterone and SHBG belong on the panel after 40.
Getting the right number measured
If symptoms have developed gradually over years, the useful test is not just total testosterone — it is total, free and SHBG together, drawn in the morning.
Keen connects you with a licensed clinical team for a telehealth consultation and lab review. If your testosterone is clinically low, treatment is Keen Testosterone Spray Rx — a once-daily topical spray powered by Hypospray® transdermal delivery.
Related reading: why testosterone declines with age for the underlying biology, free vs total testosterone, and starting TRT after 50.
References
2 sources
- Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008;93(7):2737–2745. doi:10.1210/jc.2007-1972 · PMID 18270261
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. doi:10.1210/jc.2018-00229 · PMID 29562364
Practical questions about membership, labs and using the spray are answered in the Learn Hub FAQ.
Hypospray® is a registered trademark. Keen Meds Inc. utilizes the Hypospray® topical transdermal delivery platform under license.